Concepts (282)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplasms | 29 | 2022 | 1103 | 3.770 |
Why?
|
Uterine Cervical Neoplasms | 10 | 2023 | 277 | 2.570 |
Why?
|
Breast Neoplasms | 16 | 2021 | 1502 | 2.530 |
Why?
|
Colorectal Neoplasms | 8 | 2023 | 441 | 2.220 |
Why?
|
Early Detection of Cancer | 12 | 2023 | 336 | 2.150 |
Why?
|
Health Knowledge, Attitudes, Practice | 19 | 2021 | 864 | 1.900 |
Why?
|
Humans | 96 | 2024 | 37093 | 1.640 |
Why?
|
Language | 6 | 2018 | 157 | 1.560 |
Why?
|
Mass Screening | 7 | 2021 | 462 | 1.540 |
Why?
|
Clinical Trials as Topic | 7 | 2018 | 204 | 1.530 |
Why?
|
HIV Infections | 5 | 2023 | 2303 | 1.460 |
Why?
|
Continuity of Patient Care | 8 | 2022 | 94 | 1.450 |
Why?
|
Skin Neoplasms | 4 | 2024 | 159 | 1.450 |
Why?
|
Female | 66 | 2023 | 20969 | 1.400 |
Why?
|
Adult | 44 | 2024 | 11712 | 1.370 |
Why?
|
Psychometrics | 12 | 2023 | 318 | 1.300 |
Why?
|
Patient Education as Topic | 4 | 2015 | 215 | 1.290 |
Why?
|
Biological Specimen Banks | 4 | 2018 | 25 | 1.290 |
Why?
|
Middle Aged | 46 | 2024 | 10129 | 1.290 |
Why?
|
Anti-HIV Agents | 2 | 2023 | 420 | 1.250 |
Why?
|
Health Services Accessibility | 13 | 2015 | 560 | 1.230 |
Why?
|
Male | 47 | 2024 | 20025 | 1.160 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2017 | 33 | 1.140 |
Why?
|
Healthcare Disparities | 11 | 2017 | 494 | 1.130 |
Why?
|
Self Efficacy | 8 | 2018 | 184 | 1.110 |
Why?
|
Sunbathing | 2 | 2024 | 8 | 1.110 |
Why?
|
Patient Satisfaction | 9 | 2019 | 145 | 1.050 |
Why?
|
Patient Acceptance of Health Care | 7 | 2021 | 404 | 0.990 |
Why?
|
Papillomavirus Vaccines | 3 | 2021 | 151 | 0.960 |
Why?
|
Papillomavirus Infections | 4 | 2021 | 336 | 0.930 |
Why?
|
United States | 19 | 2024 | 4223 | 0.870 |
Why?
|
Internal-External Control | 2 | 2018 | 53 | 0.830 |
Why?
|
Young Adult | 19 | 2024 | 4268 | 0.820 |
Why?
|
Breast Feeding | 3 | 2013 | 113 | 0.820 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2022 | 103 | 0.780 |
Why?
|
Alphapapillomavirus | 1 | 2021 | 38 | 0.770 |
Why?
|
Patient Advocacy | 3 | 2017 | 21 | 0.750 |
Why?
|
Florida | 11 | 2018 | 410 | 0.750 |
Why?
|
Adolescent | 16 | 2024 | 5363 | 0.740 |
Why?
|
Attitude | 4 | 2016 | 104 | 0.730 |
Why?
|
Health Personnel | 3 | 2018 | 228 | 0.710 |
Why?
|
Mental Disorders | 1 | 2023 | 309 | 0.700 |
Why?
|
Patient Participation | 4 | 2013 | 75 | 0.690 |
Why?
|
Aged | 24 | 2023 | 6741 | 0.690 |
Why?
|
Qualitative Research | 6 | 2023 | 446 | 0.680 |
Why?
|
Vulnerable Populations | 2 | 2017 | 140 | 0.670 |
Why?
|
Health Education | 5 | 2020 | 338 | 0.660 |
Why?
|
Health Status Disparities | 4 | 2014 | 642 | 0.650 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2024 | 68 | 0.650 |
Why?
|
Heterosexuality | 1 | 2019 | 88 | 0.640 |
Why?
|
Biomedical Research | 4 | 2016 | 400 | 0.640 |
Why?
|
Multimedia | 3 | 2013 | 17 | 0.640 |
Why?
|
Mammography | 2 | 2011 | 188 | 0.620 |
Why?
|
Famous Persons | 1 | 2017 | 5 | 0.610 |
Why?
|
Mastectomy | 1 | 2017 | 15 | 0.610 |
Why?
|
Research Subjects | 2 | 2018 | 32 | 0.600 |
Why?
|
Social Support | 7 | 2022 | 394 | 0.600 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2017 | 22 | 0.600 |
Why?
|
Carcinoma, Basal Cell | 1 | 2017 | 20 | 0.600 |
Why?
|
Disclosure | 1 | 2017 | 34 | 0.590 |
Why?
|
Anxiety | 4 | 2023 | 754 | 0.560 |
Why?
|
Primary Health Care | 2 | 2018 | 294 | 0.550 |
Why?
|
Melanoma | 1 | 2017 | 96 | 0.550 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2024 | 643 | 0.540 |
Why?
|
Medication Adherence | 2 | 2016 | 179 | 0.540 |
Why?
|
Mental Health | 1 | 2019 | 303 | 0.530 |
Why?
|
Quality of Health Care | 3 | 2014 | 138 | 0.530 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2017 | 178 | 0.530 |
Why?
|
Inservice Training | 1 | 2015 | 33 | 0.530 |
Why?
|
Rural Population | 2 | 2015 | 294 | 0.510 |
Why?
|
Caregivers | 3 | 2022 | 182 | 0.510 |
Why?
|
RNA Splice Sites | 1 | 2015 | 10 | 0.510 |
Why?
|
Trust | 1 | 2016 | 133 | 0.510 |
Why?
|
RNA Splicing | 1 | 2015 | 40 | 0.500 |
Why?
|
Computers | 1 | 2015 | 35 | 0.500 |
Why?
|
Sunburn | 2 | 2011 | 4 | 0.500 |
Why?
|
India | 3 | 2019 | 88 | 0.500 |
Why?
|
Cross-Sectional Studies | 10 | 2023 | 2721 | 0.490 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2015 | 40 | 0.490 |
Why?
|
Reproducibility of Results | 7 | 2023 | 935 | 0.490 |
Why?
|
Caenorhabditis elegans | 1 | 2015 | 78 | 0.480 |
Why?
|
Regional Health Planning | 1 | 2013 | 14 | 0.470 |
Why?
|
Insulin-Secreting Cells | 2 | 2024 | 28 | 0.470 |
Why?
|
Delivery of Health Care | 4 | 2022 | 276 | 0.460 |
Why?
|
Community Health Centers | 2 | 2012 | 45 | 0.460 |
Why?
|
Tissue and Organ Procurement | 1 | 2014 | 43 | 0.450 |
Why?
|
Minority Health | 1 | 2013 | 88 | 0.450 |
Why?
|
Software | 1 | 2015 | 217 | 0.440 |
Why?
|
Focus Groups | 4 | 2019 | 348 | 0.440 |
Why?
|
Vaginal Smears | 3 | 2019 | 57 | 0.430 |
Why?
|
Intention | 4 | 2018 | 94 | 0.420 |
Why?
|
Delayed Diagnosis | 1 | 2012 | 28 | 0.420 |
Why?
|
Rural Health Services | 1 | 2012 | 44 | 0.420 |
Why?
|
Depression | 4 | 2019 | 712 | 0.410 |
Why?
|
Decision Making | 4 | 2017 | 203 | 0.400 |
Why?
|
Interviews as Topic | 3 | 2019 | 381 | 0.380 |
Why?
|
Research Design | 2 | 2011 | 313 | 0.370 |
Why?
|
Socioeconomic Factors | 7 | 2018 | 1067 | 0.360 |
Why?
|
Transcription Factors | 1 | 2015 | 681 | 0.350 |
Why?
|
Schools | 1 | 2011 | 260 | 0.350 |
Why?
|
Allied Health Personnel | 1 | 2009 | 6 | 0.340 |
Why?
|
Telephone | 1 | 2009 | 34 | 0.340 |
Why?
|
Internet | 2 | 2023 | 211 | 0.340 |
Why?
|
Motivation | 3 | 2017 | 436 | 0.340 |
Why?
|
Transients and Migrants | 2 | 2021 | 39 | 0.320 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2009 | 49 | 0.320 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2008 | 26 | 0.320 |
Why?
|
Diabetes Complications | 1 | 2009 | 90 | 0.320 |
Why?
|
Medical Oncology | 3 | 2022 | 30 | 0.310 |
Why?
|
Insulin | 3 | 2024 | 236 | 0.310 |
Why?
|
Survivors | 2 | 2021 | 136 | 0.310 |
Why?
|
Self Care | 1 | 2009 | 159 | 0.300 |
Why?
|
Quality of Life | 3 | 2021 | 481 | 0.300 |
Why?
|
Communication | 3 | 2019 | 180 | 0.300 |
Why?
|
Neurons | 1 | 2015 | 1175 | 0.300 |
Why?
|
Pregnancy | 4 | 2022 | 1549 | 0.290 |
Why?
|
Homosexuality, Male | 2 | 2023 | 458 | 0.280 |
Why?
|
Protective Clothing | 3 | 2011 | 6 | 0.280 |
Why?
|
Attitude to Health | 4 | 2014 | 325 | 0.280 |
Why?
|
Immunization Programs | 3 | 2000 | 24 | 0.280 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 268 | 0.270 |
Why?
|
Aged, 80 and over | 9 | 2020 | 2379 | 0.270 |
Why?
|
Stress, Psychological | 2 | 2024 | 583 | 0.270 |
Why?
|
Glucose | 2 | 2024 | 230 | 0.270 |
Why?
|
Adaptation, Psychological | 1 | 2009 | 385 | 0.260 |
Why?
|
Vaccination | 3 | 2021 | 288 | 0.250 |
Why?
|
Registries | 3 | 2000 | 335 | 0.240 |
Why?
|
Factor Analysis, Statistical | 3 | 2018 | 146 | 0.240 |
Why?
|
Pilot Projects | 3 | 2021 | 661 | 0.230 |
Why?
|
Alternative Splicing | 1 | 2023 | 85 | 0.230 |
Why?
|
RNA-Binding Proteins | 1 | 2024 | 146 | 0.220 |
Why?
|
Mexico | 1 | 2023 | 240 | 0.210 |
Why?
|
Cation Transport Proteins | 1 | 2022 | 34 | 0.210 |
Why?
|
Interpersonal Relations | 3 | 2019 | 205 | 0.210 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2022 | 72 | 0.210 |
Why?
|
Community Networks | 2 | 2013 | 108 | 0.210 |
Why?
|
Virginia | 1 | 2021 | 10 | 0.200 |
Why?
|
Infant | 2 | 2022 | 1046 | 0.190 |
Why?
|
Risk Factors | 4 | 2017 | 3562 | 0.190 |
Why?
|
Mexican Americans | 1 | 2023 | 189 | 0.190 |
Why?
|
Demography | 1 | 2021 | 175 | 0.190 |
Why?
|
Follow-Up Studies | 5 | 2015 | 974 | 0.190 |
Why?
|
Perception | 2 | 2012 | 195 | 0.190 |
Why?
|
Risk-Taking | 1 | 2024 | 451 | 0.180 |
Why?
|
Mothers | 1 | 2022 | 181 | 0.180 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 128 | 0.180 |
Why?
|
Blogging | 1 | 2019 | 2 | 0.180 |
Why?
|
Brain Neoplasms | 1 | 2021 | 111 | 0.180 |
Why?
|
Ultraviolet Rays | 2 | 2017 | 117 | 0.170 |
Why?
|
Spouses | 1 | 2019 | 30 | 0.170 |
Why?
|
Stereotyping | 1 | 2019 | 40 | 0.160 |
Why?
|
Time Factors | 5 | 2015 | 1742 | 0.160 |
Why?
|
Fatigue | 1 | 2019 | 83 | 0.160 |
Why?
|
Puerto Rico | 2 | 2013 | 1378 | 0.160 |
Why?
|
Cultural Competency | 2 | 2018 | 131 | 0.160 |
Why?
|
Condoms | 1 | 2019 | 135 | 0.160 |
Why?
|
Child | 7 | 2021 | 3131 | 0.160 |
Why?
|
Feasibility Studies | 2 | 2018 | 208 | 0.150 |
Why?
|
Needs Assessment | 2 | 2013 | 170 | 0.150 |
Why?
|
Awareness | 1 | 2017 | 65 | 0.150 |
Why?
|
Genetic Testing | 1 | 2017 | 75 | 0.140 |
Why?
|
Models, Psychological | 1 | 2017 | 131 | 0.140 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 198 | 0.140 |
Why?
|
Chronic Disease | 2 | 2020 | 484 | 0.140 |
Why?
|
Videodisc Recording | 2 | 2013 | 4 | 0.140 |
Why?
|
Program Evaluation | 2 | 2015 | 339 | 0.140 |
Why?
|
Patient Selection | 2 | 2015 | 164 | 0.140 |
Why?
|
Medical Informatics | 1 | 2016 | 21 | 0.140 |
Why?
|
Pamphlets | 2 | 2013 | 26 | 0.140 |
Why?
|
Consumer Health Information | 1 | 2016 | 22 | 0.140 |
Why?
|
Health Services Research | 2 | 2014 | 148 | 0.140 |
Why?
|
Sex Factors | 1 | 2019 | 898 | 0.130 |
Why?
|
Confidentiality | 1 | 2015 | 26 | 0.130 |
Why?
|
California | 1 | 2017 | 476 | 0.130 |
Why?
|
Personality Inventory | 2 | 2009 | 75 | 0.130 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2015 | 39 | 0.130 |
Why?
|
Body Mass Index | 3 | 2009 | 854 | 0.130 |
Why?
|
Patient Compliance | 2 | 2007 | 212 | 0.130 |
Why?
|
Cilia | 1 | 2015 | 27 | 0.130 |
Why?
|
Morphogenesis | 1 | 2015 | 50 | 0.130 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 93 | 0.130 |
Why?
|
Estrogen Receptor Modulators | 1 | 2014 | 19 | 0.120 |
Why?
|
Protein Isoforms | 1 | 2015 | 130 | 0.120 |
Why?
|
Models, Educational | 1 | 2014 | 44 | 0.120 |
Why?
|
Health Literacy | 1 | 2016 | 105 | 0.120 |
Why?
|
Southeastern United States | 1 | 2013 | 49 | 0.120 |
Why?
|
Interinstitutional Relations | 1 | 2013 | 38 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 628 | 0.120 |
Why?
|
Health Behavior | 2 | 2010 | 537 | 0.120 |
Why?
|
Sexual Behavior | 1 | 2019 | 609 | 0.110 |
Why?
|
Cancer Care Facilities | 1 | 2013 | 17 | 0.110 |
Why?
|
Patient Care | 1 | 2013 | 29 | 0.110 |
Why?
|
Animals | 5 | 2024 | 15081 | 0.110 |
Why?
|
Spain | 1 | 2013 | 36 | 0.110 |
Why?
|
Tissue Banks | 1 | 2012 | 7 | 0.110 |
Why?
|
Patient Preference | 1 | 2013 | 44 | 0.110 |
Why?
|
Base Sequence | 1 | 2015 | 997 | 0.110 |
Why?
|
Mice | 4 | 2024 | 5913 | 0.110 |
Why?
|
Family | 1 | 2013 | 173 | 0.100 |
Why?
|
Medically Underserved Area | 2 | 2011 | 104 | 0.100 |
Why?
|
Molecular Sequence Data | 1 | 2015 | 1568 | 0.100 |
Why?
|
Odds Ratio | 2 | 2016 | 534 | 0.100 |
Why?
|
Cluster Analysis | 1 | 2011 | 195 | 0.100 |
Why?
|
Mice, Knockout | 2 | 2024 | 933 | 0.100 |
Why?
|
Multivariate Analysis | 2 | 2015 | 583 | 0.100 |
Why?
|
Program Development | 1 | 2012 | 233 | 0.100 |
Why?
|
Health Care Costs | 1 | 2011 | 77 | 0.090 |
Why?
|
Risk Reduction Behavior | 1 | 2011 | 127 | 0.090 |
Why?
|
Skin Pigmentation | 1 | 2010 | 23 | 0.090 |
Why?
|
Sunlight | 1 | 2010 | 47 | 0.090 |
Why?
|
Foot | 1 | 2009 | 10 | 0.090 |
Why?
|
Fear | 1 | 2012 | 249 | 0.090 |
Why?
|
School Health Services | 1 | 2010 | 81 | 0.080 |
Why?
|
Medicare | 2 | 2008 | 195 | 0.080 |
Why?
|
Defense Mechanisms | 1 | 2009 | 9 | 0.080 |
Why?
|
Problem Solving | 1 | 2009 | 35 | 0.080 |
Why?
|
Treatment Outcome | 2 | 2009 | 1369 | 0.080 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 803 | 0.070 |
Why?
|
Disabled Persons | 1 | 2008 | 65 | 0.070 |
Why?
|
Perinatology | 1 | 2006 | 2 | 0.070 |
Why?
|
Depressive Disorder | 1 | 2007 | 174 | 0.070 |
Why?
|
Infant, Newborn | 2 | 2015 | 894 | 0.070 |
Why?
|
Feeding Behavior | 1 | 2009 | 454 | 0.060 |
Why?
|
Prospective Studies | 2 | 2021 | 1378 | 0.060 |
Why?
|
Logistic Models | 1 | 2007 | 923 | 0.060 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2024 | 4 | 0.060 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2024 | 33 | 0.060 |
Why?
|
Exocytosis | 1 | 2023 | 47 | 0.060 |
Why?
|
Adaptation, Physiological | 1 | 2024 | 109 | 0.060 |
Why?
|
Exercise | 1 | 2009 | 613 | 0.060 |
Why?
|
Mice, Inbred NOD | 1 | 2022 | 45 | 0.050 |
Why?
|
Diet | 1 | 2009 | 801 | 0.050 |
Why?
|
Respiration | 1 | 2022 | 58 | 0.050 |
Why?
|
Mice, SCID | 1 | 2022 | 150 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2023 | 185 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 333 | 0.050 |
Why?
|
Palliative Care | 1 | 2022 | 49 | 0.050 |
Why?
|
Risk Assessment | 1 | 2005 | 753 | 0.050 |
Why?
|
Algorithms | 1 | 2005 | 465 | 0.050 |
Why?
|
Blood Glucose | 1 | 2023 | 353 | 0.050 |
Why?
|
Proteomics | 1 | 2024 | 325 | 0.050 |
Why?
|
Prognosis | 2 | 2014 | 739 | 0.050 |
Why?
|
Principal Component Analysis | 2 | 2011 | 89 | 0.050 |
Why?
|
Minority Groups | 2 | 2016 | 596 | 0.050 |
Why?
|
Workload | 1 | 2000 | 22 | 0.050 |
Why?
|
Direct Service Costs | 1 | 2000 | 1 | 0.050 |
Why?
|
Costs and Cost Analysis | 3 | 2011 | 57 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2023 | 357 | 0.050 |
Why?
|
Cost of Illness | 1 | 2020 | 76 | 0.050 |
Why?
|
Syndrome | 1 | 2019 | 74 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2022 | 885 | 0.040 |
Why?
|
Information Services | 1 | 2018 | 14 | 0.040 |
Why?
|
Agriculture | 1 | 2018 | 56 | 0.040 |
Why?
|
Peer Group | 1 | 2018 | 156 | 0.040 |
Why?
|
Narration | 1 | 2016 | 30 | 0.030 |
Why?
|
Communication Barriers | 1 | 2015 | 56 | 0.030 |
Why?
|
Mastectomy, Segmental | 1 | 2014 | 17 | 0.030 |
Why?
|
Insurance Coverage | 1 | 2015 | 100 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2015 | 146 | 0.030 |
Why?
|
Poverty | 1 | 2016 | 348 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 441 | 0.030 |
Why?
|
Translating | 1 | 2011 | 16 | 0.020 |
Why?
|
Government Programs | 1 | 2011 | 29 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2012 | 128 | 0.020 |
Why?
|
Child, Preschool | 1 | 2015 | 1418 | 0.020 |
Why?
|
Health Promotion | 1 | 2016 | 653 | 0.020 |
Why?
|
Sunscreening Agents | 1 | 2009 | 9 | 0.020 |
Why?
|
Linear Models | 1 | 2010 | 275 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2015 | 2026 | 0.020 |
Why?
|
Health Maintenance Organizations | 1 | 2008 | 13 | 0.020 |
Why?
|
Fee-for-Service Plans | 1 | 2008 | 17 | 0.020 |
Why?
|
SEER Program | 1 | 2008 | 91 | 0.020 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2008 | 88 | 0.020 |
Why?
|
Regression Analysis | 1 | 2007 | 455 | 0.020 |
Why?
|
Pennsylvania | 1 | 2005 | 42 | 0.020 |
Why?
|
Insurance Claim Review | 1 | 2005 | 28 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2008 | 358 | 0.010 |
Why?
|
Cohort Studies | 1 | 2005 | 1492 | 0.010 |
Why?
|
Ambulatory Care Facilities | 1 | 2000 | 61 | 0.010 |
Why?
|
Georgia | 1 | 2000 | 174 | 0.010 |
Why?
|
Data Collection | 1 | 2000 | 194 | 0.010 |
Why?
|
Community Health Services | 1 | 2000 | 185 | 0.010 |
Why?
|